Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thalidomide to Patients With Previously Untreated Multiple Myeloma

This study has been completed.
The Research Council of Norway
Nordic Myeloma Study Group, Germany
Information provided by (Responsible Party):
Norwegian University of Science and Technology Identifier:
First received: September 20, 2005
Last updated: March 6, 2014
Last verified: March 2014